Transforming growth factor-beta down-regulates apolipoprotein M in HepG2 cells

Area of Science:

• Biochemistry
• Molecular Biology
• Hepatology

Background:

• Apolipoprotein M (apoM) is a novel protein primarily found in high-density lipoprotein (HDL).
• Its precise pathophysiological function remains largely unelucidated.
• Apolipoprotein B (apoB), found in low-density lipoprotein (LDL), and apoM are both hydrophobic and co-circulate in plasma.

Purpose of the Study:

• To investigate the effect of transforming growth factor-beta (TGF-beta) on apolipoprotein M (apoM) expression in HepG2 cells.
• To compare the effects of TGF-beta on apoM and apoB mRNA levels.
• To examine the influence of other growth factors (TGF-alpha, EGF, HGF) on apoM and apoB mRNA expression.

Main Methods:

• Utilized real-time RT-PCR to quantify apoM and apoB mRNA levels.
• Administered TGF-beta, TGF-alpha, epidermal growth factor (EGF), and hepatic growth factor (HGF) to HepG2 cells.
• Analyzed dose-dependent and time-dependent effects of TGF-beta.

Main Results:

• TGF-beta significantly inhibited both apoM and apoB mRNA expression in a dose- and time-dependent manner.
• TGF-beta's inhibitory effect was more pronounced on apoM mRNA than apoB mRNA.
• TGF-alpha, EGF, and HGF also decreased apoM and apoB mRNA levels, but to a lesser extent than TGF-beta.

Conclusions:

• Apolipoprotein M (apoM) expression is negatively regulated by TGF-beta in HepG2 cells, similar to apoB.
• The findings suggest that apoM may be involved in hepatic lipoprotein assembly, analogous to apoB.
• Cytokines like TGF-beta play a significant role in regulating lipoprotein-related gene expression in the liver.